Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma. - Wikidata - awgldk - TriplyDB

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.

http://www.wikidata.org/entity/Q36642320

about

Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers New prognostic factors of cutaneous melanoma: a review of the literature.On the role of sIL-2R measurements in rheumatoid arthritis and cancers.A synopsis of serum biomarkers in cutaneous melanoma patients Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients.A pentacyclic triterpene natural product, ursolic acid and its prodrug US597 inhibit targets within cell adhesion pathway and prevent cancer metastasis.Role of nuclear factor-kappa B in melanoma.Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.CXC chemokine ligand 12/stromal cell-derived factor-1 regulates cell adhesion in human colon cancer cells by induction of intercellular adhesion molecule-1 Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.Increased circulation of galectin-3 in cancer induces secretion of metastasis-promoting cytokines from blood vascular endothelium.Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma A list of candidate cancer biomarkers for targeted proteomics.Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma.Human urine proteomics: building a list of human urine cancer biomarkers.Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.The expression of interleukin-10 in patients with primary ovarian epithelial carcinoma and in ovarian carcinoma cell lines.IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence Human papillomavirus typing and soluble interleukin-2 receptor levels in female sex workers with a negative cervical smear result.Serum TNF-α, B2M and sIL-2R levels are biological correlates of outcome in adjuvant IFN-α2b treatment of patients with melanoma.Dendritic Cells Actively Limit Interleukin-10 Production Under Inflammatory Conditions via DC-SCRIPT and Dual-Specificity Phosphatase 4.

P2860

Q33892988-812759C9-2D00-45BF-8F6C-D5E2501DE01A Q33959343-80662513-CD78-4656-9A98-EB8A1A7AD611 Q34756424-26FFB72C-CF24-4F6A-8615-343DD81A204F Q34894394-56B512B3-390F-4872-90D0-65E196BC2A47 Q35687399-8F7FBEC2-A164-4079-9EB2-1F6858B5ADAC Q35698637-B9DC1724-3AF2-4DE1-BC3B-A1DA93BACDAE Q35832346-B2993A3E-0A50-4804-957B-D666E4C69EE4 Q36178379-718BBA48-B6DE-45B7-ADB7-11AA316007CE Q36293343-1901CA1E-5D19-42DD-8668-2F3A480307F7 Q36369111-27E53316-7C69-4D3C-806D-1CA90C2F82DF Q36707344-B408C2F6-E68B-4292-AA90-2DE63AB01A5A Q36746178-F10B706D-2A0D-46A8-BB6D-D3576788AA1F Q36956380-1F564F2E-E09B-474E-BBCA-48E538144043 Q37004685-3639DF44-8C60-473B-B651-D1C33E7CA1AA Q37215888-ED0D9CF0-D455-4790-9B2D-64B9EAD1D83F Q37277962-B729F8F2-54E9-43C8-AF0F-4955B64F3825 Q37384738-E9498B2E-C6E5-4DFF-A32F-11D63BDAB385 Q37890422-CC74EF41-BAFC-4989-8F5C-60092461EBA0 Q40034818-685C0566-C5E6-4CB7-9B85-A821BA9F6F85 Q40097601-FFECE6DE-C909-4070-B3AF-1FE6A8B690BC Q40115028-180793A6-7C4A-443D-A9F3-0983011D39DB Q42698829-79FA7505-A85B-45AE-BE0E-438B58DC660C Q47740892-1622B03C-5544-4F7B-8C70-2F5963141628 Q52903912-FA735FF6-C35F-4B15-B19E-AFBF9B939934 Q55514821-C295036B-F9AF-4D98-9113-A2EB4D411972

P2860

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.

http://www.wikidata.org/entity/Q36642320

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Soluble interleukin-2 receptor ...... els in patients with melanoma.

@ast

Soluble interleukin-2 receptor ...... els in patients with melanoma.

@en

type

label

Soluble interleukin-2 receptor ...... els in patients with melanoma.

@ast

Soluble interleukin-2 receptor ...... els in patients with melanoma.

@en

prefLabel

Soluble interleukin-2 receptor ...... els in patients with melanoma.

@ast

Soluble interleukin-2 receptor ...... els in patients with melanoma.

@en

P1433

Q36642320-4548C6B1-9B33-4B1F-BDB2-46EE0E20FDFE

P1476

Q36642320-7F0CCF18-D95D-43E3-B031-A29B7F31BC67

P2093

Q36642320-035A22EF-38D7-4FED-BBD9-C09E4887ECA4

Q36642320-0AB979A6-4345-4F83-8B31-BC38568CF386

Q36642320-3D6EE4E7-D580-4511-BDB2-F5C386D2CC8B

Q36642320-465DC776-C2C7-4B5D-9BD6-214366D05320

Q36642320-4EA6FDC1-3436-4086-A7DC-D7204A22AF56

Q36642320-51AFA0C0-EA17-4DA9-A656-1E8326F0E830

Q36642320-697CCB69-A63F-4CE5-8A35-69C944448C9F

Q36642320-905D2F5D-B14D-4F3D-AF99-993EB702B548

Q36642320-B2D45E04-18B1-439B-B0CF-8137A1298DAE

Q36642320-C7781B9B-B478-488D-B818-EE2EE39ABABF

P2860

Q36642320-1E03E370-F952-4D53-8BDF-A62657F96C61

Q36642320-235CCC23-9ACB-432F-A3A8-51B0D426D378

Q36642320-281F16D1-7CF1-4003-922C-4C648D0CEA34

Q36642320-4D9AAB56-3DF5-4D66-B897-0A28466AF692

Q36642320-4E3B92C2-A7B1-41FD-A7A7-C504327E2642

Q36642320-641A0141-F26F-4F86-BDF8-C709E6B67DA3

Q36642320-67359FDA-2B95-441D-95A5-139ADDBE95DE

Q36642320-68F39A9B-E2EB-4EC6-8297-A0F5ED1DD490

Q36642320-6AED28BB-4E02-4F88-8B3A-355AC1B9BACE

Q36642320-7D95F096-F150-44CF-B55D-2242D7B56940

P2888

Q36642320-F12CB7C5-9BC3-4344-9E58-BB74C7D54EEF

P304

Q36642320-59599E73-C032-4B48-9540-AD9EA5D207E1

P31

Q36642320-513003C6-BCC9-41A9-A1E8-9B75437E5990

P356

Q36642320-FF7E08F5-E3EA-4989-AB4E-6380338F8DF9

P407

Q36642320-88EE815D-F2B6-4E13-8D16-8A83DBBC8266

P433

Q36642320-355BD1B0-2C83-4933-82F0-6DFD151D83C4

P478

Q36642320-DAFA7806-FC40-4E0A-8C84-C534F030D6D1

P577

Q36642320-04C65BE5-1B87-4769-B29C-D2C69C21A20F

P5875

Q36642320-0758ADEE-6158-45D3-A35B-30F3EB73CA12

P6179

Q36642320-1E88AA96-3E3B-41F2-9502-27EEB830F7A4

P698

Q36642320-116D4383-61AD-4BCE-BF1D-F23A49561D4A

P932

Q36642320-B0A366FC-BF46-41C9-A5BD-974EB2E932CC

P356

P1433

British Journal of Cancer

P1476

Soluble interleukin-2 receptor ...... els in patients with melanoma.

@en

P2093

Bilbao J

http://www.w3.org/2001/XMLSchema#string

Boyano MD

http://www.w3.org/2001/XMLSchema#string

Cañavate ML

http://www.w3.org/2001/XMLSchema#string

Díaz-Pérez JL

http://www.w3.org/2001/XMLSchema#string

Díaz-Ramón L

http://www.w3.org/2001/XMLSchema#string

Galdeano AG

http://www.w3.org/2001/XMLSchema#string

Garcia-Vázquez MD

http://www.w3.org/2001/XMLSchema#string

Gardeazabal J

http://www.w3.org/2001/XMLSchema#string

Izu R

http://www.w3.org/2001/XMLSchema#string

López-Michelena T

http://www.w3.org/2001/XMLSchema#string

P2860

Association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin 2 receptor

IL-10 inhibits cytokine production by activated macrophages

De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.

Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm

Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies.

Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma.

Soluble cytokine receptors: their role in immunoregulation.

The soluble interleukin-2 receptor: biology, function, and clinical application.

The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus.

Cytokine sensitivity of metastatic human melanoma cell lines-- simultaneous inhibition of proliferation and enhancement of gelatinase activity.

P2888

P304

847-852

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.2000.1402

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2000-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12350793

http://www.w3.org/2001/XMLSchema#string

P6179

1006640886

http://www.w3.org/2001/XMLSchema#string

P698

10970683

http://www.w3.org/2001/XMLSchema#string

P932

2374688

http://www.w3.org/2001/XMLSchema#string